Keywords: once-daily, kaletra, shows, promise, new, data, released

Once-daily Kaletra shows promise

Article | 23 February 2004

Print This

New data released by Abbott Laboratories shows that a once-daily dose of its HIV protease inhibitor Kaletra (lopinavir/ritonavir) had ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in